Detalhe da pesquisa
1.
Joint models for dynamic prediction in localised prostate cancer: a literature review.
BMC Med Res Methodol
; 22(1): 245, 2022 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123621
2.
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.
Lancet Oncol
; 22(2): 246-255, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539743
3.
Biomarkers for site-specific response to neoadjuvant chemotherapy in epithelial ovarian cancer: relating MRI changes to tumour cell load and necrosis.
Br J Cancer
; 124(6): 1130-1137, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398064
4.
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI).
Int J Gynecol Cancer
; 31(11): 1471-1475, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518240
5.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806540
6.
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer.
BJU Int
; 125(6): 817-826, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124514
7.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510020
8.
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004).
Br J Cancer
; 116(5): 649-657, 2017 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28125821
9.
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.
Radiology
; 283(1): 168-177, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27875103
10.
The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma.
Br J Cancer
; 113(9): 1275-81, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26484413
11.
Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission.
Eur J Clin Pharmacol
; 70(3): 361-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362489
12.
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial.
EBioMedicine
; 101: 105032, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387404
13.
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Cell Rep Med
; 5(3): 101435, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417447
14.
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.
Eur J Cancer
; 205: 114103, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729054
15.
Clinical trial designs for evaluating and exploiting cancer evolution.
Cancer Treat Rev
; 118: 102583, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331179
16.
A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 Trial.
Int J Radiat Oncol Biol Phys
; 116(5): 1055-1068, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822374
17.
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.
Radiother Oncol
; 183: 109592, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870608
18.
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study.
Insights Imaging
; 14(1): 170, 2023 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840055
19.
A dynamic model for the risk of bladder cancer progression.
Stat Med
; 31(3): 287-300, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22161505
20.
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial.
Eur Urol
; 82(3): 273-279, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577644